Infinity Pharma (INFI) Reschedules Q3 Report, Conf. Call; Notes Post-Quarter Events

November 4, 2016 6:48 AM EDT
Get Alerts INFI Hot Sheet
Trade INFI Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) announced that it has moved the date of its third quarter 2016 financial results conference call and webcast from Monday, November 7, 2016, at 4:30 p.m. ET to Wednesday, November 9, 2016, at 4:30 p.m. ET. The change in date is reflect subsequent events that occurred after the end of the quarter, including the license of duvelisib to Verastem, Inc. During the call on Wednesday, November 9, 2016, management will review the company's third quarter 2016 financial results and provide an update on Infinity's business.

A live webcast of the conference call can be accessed in the Investors/Media section of Infinity's website at To participate in the conference call, please dial 1-877-316-5293 (domestic) and 1-631-291-4526 (international) five minutes prior to start time. The conference ID number is 1138542. An archived version of the webcast will be available on Infinity's website for 30 days.

Contact:Jaren MaddenSenior Director, Investor Relations and Corporate Communications617-453-1336 or

Logo -

To view the original version on PR Newswire, visit:

SOURCE Infinity Pharmaceuticals, Inc.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Conference Calls, Corporate News, Earnings

Related Entities


Add Your Comment